Wu, Ce <br/><br/>
Bioinformatic profiling identifies a platinum-resistant-related risk signature for ovarian cancer.  [electronic resource] 

 -  Cancer medicine  02 2020 
 - 1242-1253 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2045-7634 
<br/><br/><label>Standard No.: </label>10.1002/cam4.2692  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Biomarkers, Tumor--genetics<br/>Computational Biology<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Datasets as Topic<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Models, Genetic<br/>Oligonucleotide Array Sequence Analysis--statistics & numerical data<br/>Organoplatinum Compounds--pharmacology<br/>Ovarian Neoplasms--drug therapy<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Prognosis<br/>Progression-Free Survival<br/>RNA, Messenger<br/>ROC Curve<br/>Transcriptome--genetics